Awaiting the consolidation of Equans

12/05/22 -"The Bouygues Q1 was in line with expectations and the outlook for 2022 given three months ago was maintained. The planned acquisition of Equans and the proposed TF1-M6 merger remain on schedule. ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

12/05/22

Download

You may also be interested by these reports :

28/11/25

Bolloré , Vivendi

Unsurprisingly, the French Supreme Court cancelled the judgement of the Paris Appeal Court but asked the Paris Appeal Court to judge again if Bolloré ...

28/11/25

Sonae

Following the release of the more detailed 9M report, we have improved our EPS for 2025, mainly due to lower depreciation costs expected for 2025 ...

26/11/25

Hal Trust

HAL continued its momentum in Q3 2025 by recording a slight increase in NAV, supported by its private assets. However, the performance was mixed ...

25/11/25

ACKERMANS & VAN HAAREN

How Ackermans turns discipline into returns

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue